Skip Nav Destination
Issues
June 2017
-
Cover Image
Cover Image
- PDF Icon PDF LinkFront Matter
ISSN 2235-1795
EISSN 1664-5553
In this Issue
Liver Cancer 2017, Vol. 6, No. 3
Editorial
A New Era of Systemic Therapy for Hepatocellular Carcinoma with Regorafenib and Lenvatinib
Liver Cancer (2017) 6 (3): 177–184.
https://doi.org/10.1159/000462153
Albumin-Bilirubin Grade and Hepatocellular Carcinoma Treatment Algorithm
Liver Cancer (2017) 6 (3): 185–188.
https://doi.org/10.1159/000462199
Invited Review
How to Differentiate Borderline Hepatic Nodules in Hepatocarcinogenesis: Emphasis on Imaging Diagnosis
Liver Cancer (2017) 6 (3): 189–203.
https://doi.org/10.1159/000455949
Original Paper
Albumin-Bilirubin (ALBI) Grade as Part of the Evidence-Based Clinical Practice Guideline for HCC of the Japan Society of Hepatology: A Comparison with the Liver Damage and Child-Pugh Classifications
Atsushi Hiraoka; Takashi Kumada; Masatoshi Kudo; Masashi Hirooka; Kunihiko Tsuji; Ei Itobayashi; Kazuya Kariyama; Toru Ishikawa; Kazuto Tajiri; Hironori Ochi; Toshifumi Tada; Hidenori Toyoda; Kazuhiro Nouso; Kouji Joko; Hideki Kawasaki; Yoichi Hiasa; Kojiro Michitaka; on behalf of the Real-Life Practice Experts for HCC (RELPEC) Study Group and HCC 48 Group (hepatocellular carcinoma experts from 48 clinics)
Liver Cancer (2017) 6 (3): 204–215.
https://doi.org/10.1159/000452846
The Overall Survival of Patients with Hepatocellular Carcinoma Correlates with the Newly Defined Time to Progression after Transarterial Chemoembolization
Tadaaki Arizumi; Kazuomi Ueshima; Mina Iwanishi; Tomohiro Minami; Hirokazu Chishina; Masashi Kono; Masahiro Takita; Norihisa Yada; Satoru Hagiwara; Yasunori Minami; Hiroshi Ida; Yoriaki Komeda; Mamoru Takenaka; Toshiharu Sakurai; Tomohiro Watanabe; Naoshi Nishida; Masatoshi Kudo
Liver Cancer (2017) 6 (3): 227–235.
https://doi.org/10.1159/000475777
Beneficial Effect of Maintaining Hepatic Reserve during Chemotherapy on the Outcomes of Patients with Hepatocellular Carcinoma
Takeshi Terashima; Tatsuya Yamashita; Kuniaki Arai; Kazunori Kawaguchi; Kazuya Kitamura; Taro Yamashita; Yoshio Sakai; Eishiro Mizukoshi; Masao Honda; Shuichi Kaneko
Liver Cancer (2017) 6 (3): 236–249.
https://doi.org/10.1159/000472262
The APPLE Association President's Message
Liver Cancer (2017) 6 (3): 251.
https://doi.org/10.1159/000477527